The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians about the illegal production and sale of unregistered B-GAG mist pot CIT syrup.
This warning is outlined in public notice No. 023/2024, issued by the agency’s Director-General, Prof. Mojisola Adeyeye, in Abuja on Sunday.
The unregistered product is reportedly sold by Babban Gida Agalawa General Enterprises.
According to the statement, the product, packaged in a PET bottle, was discovered during a surveillance operation by the NAFDAC Post Marketing Surveillance Directorate Officers in Maiduguri, Borno, and Keffi, Nasarawa States.
It was found that the product lacks a NAFDAC registration number and has a misleading label.
NAFDAC emphasized that the illegal marketing of medicines or counterfeit medicines poses a significant risk to public health.
Prof. Adeyeye noted that without regulatory compliance, the safety, quality, and efficacy of such products cannot be guaranteed.
The agency identified the batch number of the fake product as 0070, the manufacturing date as 01/02/2024, and the expiry date as 01/02/2027.
The manufacturer’s address was given as No. 883/884 Western Bypass Ring Road, Kumbosto Local Government, Kano State.
Adeyeye added that NAFDAC Zonal Directors and State Coordinators have been instructed to conduct surveillance to remove the illegal products within their jurisdictions.
She advised consumers and caregivers to avoid using the product and to only obtain medical products from authorized and licensed suppliers.
Adeyeye also stressed the importance of checking the authenticity and physical condition of products before purchasing.
She urged healthcare professionals and consumers to report any suspicion of the sale of substandard or falsified medicines or medical devices to the nearest NAFDAC office.
Additionally, Adeyeye called on the public to report any adverse reactions to NAFDAC at 0800-162-3322 or via email at sf.alert@nafdac.gov.ng.
She encouraged healthcare professionals and patients to report adverse events or side effects related to medicinal products through NAFDAC’s E-reporting platforms, available at www.nafdac.gov.ng, the Med-safety application on Android and iOS stores, or via email at pharmacovigilance@nafdac.gov.ng.
The notice about the product will also be uploaded to the World Health Organization (WHO) Global Surveillance and Monitoring System (GSMS).
………
Note : To submit Press Releases, Statements, and Advert Inquiries for publication on Waffi blog (website) or Television 📺, please use the following contact details: You can send an email to info@waffitv.com or reach us via Whatsapp at 07068286500
